Synapse Hellenic Pharmaceuticals & Services

Synapse Hellenic Pharmaceuticals & Services is a Greek pharmaceutical company based in Thessaloniki that specializes in the development, manufacturing, and distribution of botanical-based therapeutic products and dietary supplements. The company's primary focus is on urological health, notably through its commercial product Prostanoa Rx, which utilizes Serenoa Repens extract for the treatment of Benign Prostatic Hyperplasia (BPH). Synapse is also active in clinical research, having sponsored Phase 4 studies for combination therapies targeting chronic bacterial prostatitis and topical treatments for osteoarthritic pain. Additionally, the firm operates a Drug Information Center to provide clinical decision support and enhance medication safety. The company is registered as a general partnership and serves the Greek and broader European healthcare markets.